Number of the records: 1
antigény CD20
SYS d018951 LBL 00000nz--a2200000o--4500 005 20250606213539.0 008 950526|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 065 $a D23.050.301.264.035.120 065 $a D23.050.301.264.051.120 065 $a D23.101.100.110.120 065 $a D23.101.100.150.120 066 $a 01 $c 03 150 $a antigény CD20 $x AD $x AE $x AN $x BI $x BL $x CF $x CH $x CL $x DE $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PO $x RE $x TO $x TU $x UL $x UR $2 slo 450 $w v $a CD20 Antigens $2 eng 550 $7 sllk_us_auth*d000069283 $Y Rituximab $w p $a rituximab 550 $7 sllk_us_auth*d000069283 $Y Rituximab $w b $a rituximab 665 $a 1996; use CD20 ANTIGEN 1988-95 $2 eng 665 $a Antigens, CD (1990-1995) $2 eng 665 $a Antigens, Differentiation, B-Lymphocyte (1988-1995) $2 eng 680 9-
$i Unglycosylated phosphoproteins expressed only on B-cells. They are regulators of transmembrane Ca2+ conductance and thought to play a role in B-cell activation and proliferation. $2 eng 750 -2
$a Antigens, CD20 $2 eng 980 $x M
Number of the records: 1